Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3)** is a predicted processed pseudogene related to the gene encoding eukaryotic translation elongation factor 1 gamma (EEF1G)[1][3][5]. EEF1G is a structural and regulatory subunit of the eukaryotic translation elongation factor 1 complex, which is involved in protein synthesis, but EEF1GP3 itself is not protein-coding and is not considered a functional gene or therapeutic target[1][3]. According to genome sequence analyses, EEF1GP3 is predicted by computational methods and is not supported by experimental evidence for any protein- or RNA-coding function currently[1]. There is no direct information on biological functions, disease roles, drug interactions, or clinical utility for EEF1GP3.\n\n**Key details and context:**\n- EEF1GP3 is classified as a pseudogene, meaning it is a DNA sequence related to a gene but typically non-functional due to mutations or lack of regulatory elements necessary for expression[1][3][5].\n- Unlike some other pseudogenes which may be transcribed into non-coding RNAs with potential regulatory functions, EEF1GP3 is only predicted computationally and is not experimentally validated to show any expression or function[1].\n- Pseudogenes of the EEF1G family, including EEF1GP3, are not considered therapeutic targets or druggable entities[1].\n- EEF1G (the functional gene) is part of the elongation factor 1 complex involved in translational elongation in eukaryotes, but there is no evidence that its pseudogenes, such as EEF1GP3, participate in these or other biological functions[1][2][4].\n- There are no known interacting drugs, mechanisms of action, biomarker roles, or safety concerns for EEF1GP3.\n\n**Additional notes:**\n- EEF1GP3 should not be confused with EEF1G, the functional gene.\n- Because it is a predicted pseudogene with no known transcription or function, EEF1GP3 is not considered a \"target\" in drug discovery or molecular medicine[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3).